Making a difference in transplantation
Medical advances in organ transplantation have transformed the prospects for people suffering from irreversible organ failure.
Every year about 2,700 people in the UK take on a new lease of life after receiving an organ donated from another person (Source: NHS Blood and Transplant).
The challenge today is to increase the number of organ donors so that more people can benefit from transplants and to prolong the survival of transplanted organs so their recipients live as long and as healthily as possible.
Roche’s treatments are designed to support the long-term survival of transplanted organs, without compromising patients’ health and quality of life in other ways.